0001209191-20-016240.txt : 20200304 0001209191-20-016240.hdr.sgml : 20200304 20200304170747 ACCESSION NUMBER: 0001209191-20-016240 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200302 FILED AS OF DATE: 20200304 DATE AS OF CHANGE: 20200304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Steinkrauss William CENTRAL INDEX KEY: 0001772403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30347 FILM NUMBER: 20688211 MAIL ADDRESS: STREET 1: C/O CURIS, INC., STREET 2: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CURIS INC CENTRAL INDEX KEY: 0001108205 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043505116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-503-6500 MAIL ADDRESS: STREET 1: 4 MAGUIRE ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-02 0 0001108205 CURIS INC CRIS 0001772403 Steinkrauss William 4 MAGUIRE ROAD LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Employee stock option (right to buy) 1.26 2020-03-02 4 A 0 385000 0.00 A 2030-03-01 Common stock 385000 385000 D The option grant described in this Form 4 filing vests as to 25% of the original shares on March 2, 2021 and as to an additional 6.25% of the original shares each successive quarter and until March 2, 2024. /s/ William Steinkrauss 2020-03-04